Cargando…
Role of TRPM7 in cardiac fibrosis: A potential therapeutic target (Review)
Cardiac fibrosis is a hallmark of cardiac remodeling associated with nearly all forms of heart disease. Clinically, no effective therapeutic drugs aim to inhibit cardiac fibrosis, owing to the complex etiological heterogeneity and pathogenesis of this disease. A two-in-one protein structure, a ubiqu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792474/ https://www.ncbi.nlm.nih.gov/pubmed/33456540 http://dx.doi.org/10.3892/etm.2020.9604 |
_version_ | 1783633814182952960 |
---|---|
author | Hu, Feng Li, Meiyong Han, Fengyu Zhang, Qing Zeng, Yuhao Zhang, Weifang Cheng, Xiaoshu |
author_facet | Hu, Feng Li, Meiyong Han, Fengyu Zhang, Qing Zeng, Yuhao Zhang, Weifang Cheng, Xiaoshu |
author_sort | Hu, Feng |
collection | PubMed |
description | Cardiac fibrosis is a hallmark of cardiac remodeling associated with nearly all forms of heart disease. Clinically, no effective therapeutic drugs aim to inhibit cardiac fibrosis, owing to the complex etiological heterogeneity and pathogenesis of this disease. A two-in-one protein structure, a ubiquitous expression profile and unique biophysical characteristics enable the involvement of transient receptor potential melastatin-subfamily member 7 (TRPM7) in the pathogenesis and development of fibrosis-related cardiac diseases, such as heart failure (HF), cardiomyopathies, arrhythmia and hyperaldosteronism. In response to a variety of stimuli, multiple bioactive molecules can activate TRPM7 and related signaling pathways, leading to fibroblast proliferation, differentiation and extracellular matrix production in cardiac fibroblasts. TRPM7-mediated Ca(2+) signaling and TGF-β1 signaling pathways are critical for the formation of fibrosis. Accumulating evidence has demonstrated that TRPM7 is a potential pharmacological target for halting the development of fibrotic cardiac diseases. Reliable drug-like molecules for further development of high-affinity in vivo drugs targeting TRPM7 are urgently needed. The present review discusses the widespread and significant role of TRPM7 in cardiac fibrosis and focuses on its potential as a therapeutic target for alleviating heart fibrogenesis. |
format | Online Article Text |
id | pubmed-7792474 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-77924742021-01-14 Role of TRPM7 in cardiac fibrosis: A potential therapeutic target (Review) Hu, Feng Li, Meiyong Han, Fengyu Zhang, Qing Zeng, Yuhao Zhang, Weifang Cheng, Xiaoshu Exp Ther Med Review Cardiac fibrosis is a hallmark of cardiac remodeling associated with nearly all forms of heart disease. Clinically, no effective therapeutic drugs aim to inhibit cardiac fibrosis, owing to the complex etiological heterogeneity and pathogenesis of this disease. A two-in-one protein structure, a ubiquitous expression profile and unique biophysical characteristics enable the involvement of transient receptor potential melastatin-subfamily member 7 (TRPM7) in the pathogenesis and development of fibrosis-related cardiac diseases, such as heart failure (HF), cardiomyopathies, arrhythmia and hyperaldosteronism. In response to a variety of stimuli, multiple bioactive molecules can activate TRPM7 and related signaling pathways, leading to fibroblast proliferation, differentiation and extracellular matrix production in cardiac fibroblasts. TRPM7-mediated Ca(2+) signaling and TGF-β1 signaling pathways are critical for the formation of fibrosis. Accumulating evidence has demonstrated that TRPM7 is a potential pharmacological target for halting the development of fibrotic cardiac diseases. Reliable drug-like molecules for further development of high-affinity in vivo drugs targeting TRPM7 are urgently needed. The present review discusses the widespread and significant role of TRPM7 in cardiac fibrosis and focuses on its potential as a therapeutic target for alleviating heart fibrogenesis. D.A. Spandidos 2021-02 2020-12-27 /pmc/articles/PMC7792474/ /pubmed/33456540 http://dx.doi.org/10.3892/etm.2020.9604 Text en Copyright: © Hu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Review Hu, Feng Li, Meiyong Han, Fengyu Zhang, Qing Zeng, Yuhao Zhang, Weifang Cheng, Xiaoshu Role of TRPM7 in cardiac fibrosis: A potential therapeutic target (Review) |
title | Role of TRPM7 in cardiac fibrosis: A potential therapeutic target (Review) |
title_full | Role of TRPM7 in cardiac fibrosis: A potential therapeutic target (Review) |
title_fullStr | Role of TRPM7 in cardiac fibrosis: A potential therapeutic target (Review) |
title_full_unstemmed | Role of TRPM7 in cardiac fibrosis: A potential therapeutic target (Review) |
title_short | Role of TRPM7 in cardiac fibrosis: A potential therapeutic target (Review) |
title_sort | role of trpm7 in cardiac fibrosis: a potential therapeutic target (review) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792474/ https://www.ncbi.nlm.nih.gov/pubmed/33456540 http://dx.doi.org/10.3892/etm.2020.9604 |
work_keys_str_mv | AT hufeng roleoftrpm7incardiacfibrosisapotentialtherapeutictargetreview AT limeiyong roleoftrpm7incardiacfibrosisapotentialtherapeutictargetreview AT hanfengyu roleoftrpm7incardiacfibrosisapotentialtherapeutictargetreview AT zhangqing roleoftrpm7incardiacfibrosisapotentialtherapeutictargetreview AT zengyuhao roleoftrpm7incardiacfibrosisapotentialtherapeutictargetreview AT zhangweifang roleoftrpm7incardiacfibrosisapotentialtherapeutictargetreview AT chengxiaoshu roleoftrpm7incardiacfibrosisapotentialtherapeutictargetreview |